Skip to main content

OpenGamma Raises $10 Million for Expansion

OpenGamma looks to release more products in the next 18 months and expand in US and Asia.

piggy-bank-funds-raising-capital

Derivatives analytics firm OpenGamma has raised $10 million in its latest funding round as it aims to release two new products in the next 18 months.

The funding round, its fifth so far, or Series E, was led by VC firm Dawn Capital and supported by existing OpenGamma investors Accel, CME Ventures, and former SunGard chief executive Cristobal Conde.

Maxime Jeanniard, OpenGamma’s chief operating officer, says the funding round was geared toward further expansion.

“This funding round comes on

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

The enshittification of AI

The Waters Wrap: AI may look good to its developers, but there are a few problems lurking below the surface that might cause problems. Max Bowie explains.

DTCC dives into public cloud

The clearing house has begun migrating its equities clearing and settlement systems to AWS, while its tokenization systems have migrated to Microsoft Azure ahead of their launch this fall.

MCP is dead, long live MCP

The Waters Wrap: Reb dives into the trenches of the online developer community to see whether its reputation as the great enabler of the AI age is justified.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here